Walgreens Q2 adj. EPS down 27% from a year ago to $1.16, but above the FactSet consensus $1.10
Walgreens Q2 sales up 3.3% to $34.9 bln, beating the FactSet consensus $33.5 bln; stock jumps 1.8% premarket
Why I abandoned my 529 college savings plan and switched to Series I bonds instead
This fund manager is excited by turmoil and is snapping up energy companies, shopping malls and home builders.
Disney Drops Metaverse Hopes. The 'Next Storytelling Frontier' Is Out of Favor.
D.A. Davidson hikes price target for First Citizens BancShares but remains neutral on the stock after rally
The Metaverse Suffers a Setback. That’s OK, Banking Regulation Needs to Catch Up.
Bowlero started at buy with $26 stock price target at Stifel Nicolaus
Alibaba stock up 6.6% in premarket trade on plan to form six units
CytomX Therapeutics stock price target cut to $2 from $4 at Mizuho
Unity Biotechnology stock price target cut to $6 from $12 at Mizuho
Marathon Petroleum downgraded to neutral from overweight at J.P. Morgan
McCormick stock rises after profit beats expectations and sales rise to a record, with price increases helping offset volume declines
McCormick & Co. Q1 adj. earnings 59c beats analyst view of 50c
McCormick & Co. Q1 revenue up 3% to $1.57 bln, ahead of $1.54 bln analyst estimate
McCormick forecasts 2023 earnings of $2.56 to $2.61 a share, compared to Wall Street view of $2.57 a share
McCormick sees FY2023 adj. EPS $2.56-$2.61, surrounds FactSet consensus $2.57
McCormick Q1 sales rose 3% to $1.57 bln, above the FactSet consensus $1.55 bln
Virtual Stock Exchange